Sun Pharma spends $576m to get hands on hair loss drug
The Indian company decides to purchase Concert Pharmaceuticals, which is developing deuruxolitinib as a potential treatment for alopecia areata.
The Indian company decides to purchase Concert Pharmaceuticals, which is developing deuruxolitinib as a potential treatment for alopecia areata.
Evidence shows that animal models currently dominating bioavailability estimates are poor predictors and human, cell-based multi-organ microphysiological systems (MPS) should be investigated, CN Bio says.
Research emerging from the University of Toronto found that using machine learning models was able to guide the design of long-acting drug formulations.
The CDMO will manufacture the API for the biotech’s lead drug candidate, ahead of plans to begin clinical trials.
Amgen joins the Winn Award Program that was set up by Bristol Myers Squibb, with plans to extend the reach of clinical trials into underserved patient populations in the US.